January 30, 2020
Rose
"Hospitals and patients are still getting killed by new million-dollar drugs that won't see any competition for decades," said Dan Kistner, group senior vice president of pharmacy solutions for Vizient. In other pharmaceutical news: Roche posts its growth report, Novartis' gene therapy for infants continues to perform well, CVS figures out a way to help with diabetes medication costs, and scientists dig into the phenomenon of biotech's "missing girls."
from Kaiser Health News https://ift.tt/315MD6A
January 30, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Longer Looks: Schizophrenia, ‘Forever Chemicals,’ The Story Behind The Ebola Vaccine And More- Tensions Escalate Over Planned Pro-Gun Rally In Virginia’s Capital After FBI Arrests 3 Suspected Neo-Nazis
- State Highlights: Denver, D.C. Clear Homeless Camps; Utah Governor Abruptly Ends Distribution Of Condoms With Suggestive Phrases On Wrappers
- Can House Ways And Means Committee Break Through Gridlock On Hill Over Surprise Medical Bills?
- HHS Rule Would Roll Back Requirement That Faith-Based Services Inform Patients Of Services They Don’t Provide
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment